A surplus is better than a shortage – but not always:
While experts say an excess is better than a shortage, too large a surplus could hamper the government’s goal of steadily increasing the production and use of flu vaccines. Because makers, distributors, doctors and health departments lose money from vaccine they cannot sell to patients, they may be discouraged from making or ordering as much in coming years — potentially leading to future shortages.
